Despite the apparent sensitivity of NMJ development to impaired protein synthesis, the precise relationship between CMT2D pathogenesis and loss of GlyRS canonical function remains unclear, as not all CMT2D-causing GARS1 variants impair aminoacylation activity (Nangle et al., 2007). This evidence concerns the gene GARS1 and Charcot-Marie-Tooth disease type 2D.